Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026)
Sensus Healthcare (SRTS) recorded quarterly Cash from Investing Activities of -$3000.0 in Q1 2026, up 98.1% quarter-over-quarter from -$158000.0 in Q4 2025, and up 57.14% on a YoY basis from -$1909.1 in Q1 2025.
Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Sensus Healthcare's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 57.14% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$192000.0 (down 284.0% YoY), while the FY2025 annual figure was -$196000.0, up 28.99% from the prior year.
- Cash from Investing Activities was -$3000.0 for Q1 2026 at Sensus Healthcare, up from -$158000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $15.0 million in Q1 2022 to a low of -$337000.0 in Q3 2024.
- Historically, Cash from Investing Activities has averaged $886187.5 across 5 years, with a median of -$18500.0 in 2022.
- Biggest YoY gain for Cash from Investing Activities was 18795.0% in 2022; the steepest drop was 1900.0% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$10000.0 in 2022, then surged by 410.0% to $31000.0 in 2023, then jumped by 858.06% to $297000.0 in 2024, then plunged by 153.2% to -$158000.0 in 2025, then surged by 98.1% to -$3000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$3000.0 (Q1 2026), -$158000.0 (Q4 2025), and -$4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Sensus Healthcare | 45.77 Mn | 27.44 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Sep 30, 2023 | 31,000.00 |